A widely perceived requirement for validation of all new specimen collection swabs by the laboratory appears to be the result of misinformation. Neither the College of American Pathologists (CAP) nor regulations through the Clinical Laboratory Improvement Amendments (CLIA) address specifically the
No takes yet. Share an insight, caveat, or question.
Miller et al. (2013) studied this question.